Zacks.com on MSN16h
10x Genomics (TXG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
The market expects 10x Genomics (TXG) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended December 2024. This widely-known consensus ...
GEN7d
After a Year of Launches, 10x Refocuses on Customer Support, Biopharma Market Growth
CEO Serge Saxonov, PhD, says provider of single cell, spatial, and in situ instruments expects to see benefits from sales ...
Hosted on MSN3h
Cathie Wood’s ARK Investment buys 77.6K shares of 10x Genomics today
EST Cathie Wood’s ARK Investment buys 77.6K shares of 10x Genomics (TXG) today Published first on TheFly – the ultimate source for ...
Impacts8d
7 Best Cryptos to Buy for 10X Potential in 2025 – Don’t Miss Out on Doge Uprising’s Presale!
With institutional adoption on the rise and retail investors looking for the next big thing, these seven cryptocurrencies are ...
10x Genomics (TXG) Receives a Hold from Bank of America Securities
In a report released today, Michael Ryskin from Bank of America Securities maintained a Hold rating on 10x Genomics (TXG – Research Report).